bpc-157 tendon-to-bone healing animal studies People talk about like it's one thing. It isn't. Oral BPC-157 stays local. It survives digestion long enough to act on the GI mucosa, then clears before it reaches systemic circulation Orthopedic Use of BPC-157 -

Peptides are not ready to use

Injecting too far from the injury site Local injections work best for tendon or joint injuries

Not FDA-approved for any use

This HO-1-dependent cytoprotective mechanism may explain much of BPC-157s observed ability to protect cells against ischaemia-reperfusion injury and oxidative damage across multiple tissue types simultaneously

Together, they create an optimal healing environment that reduces recovery time by 30-50% compared to natural healing in many reported cases

Another possibly beneficial and important effect of DSIP is its importance in withdrawal from opioids, when, together with exogenously administered morphine, it was able to modulate opioid peptidergic systems, and in chronic pain, where the results of the study stated a significant reduction in pain attacks in patients with chronic pain and depressive states